Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide

J Cardiovasc Pharmacol. 1992 Jul;20(1):11-7.


The mode of action of KRN2391 [N-cyano-N'-(2-nitroxyethyl)-3- pyridinecarboximidamide monomethanesulfonate] in coronary circulation was examined in anesthetized dogs in comparison with those of nicorandil and nifedipine. Administration of KRN2391 (10 micrograms/kg i.v.), nicorandil (300 micrograms/kg i.v.), and nifedipine (3 micrograms/kg i.v.) caused an increase in coronary blood flow (CBF) and decreases in mean blood pressure (MBP) and in coronary vascular resistance (CVR). Heart rate (HR) was slightly and simultaneously increased by the drugs. Glibenclamide (5 mg/kg i.v.) blocked the changes of these parameters caused by KRN2391 and nicorandil, but not those caused by nifedipine. The present study suggests that the mechanism of action through ATP-sensitive K channels which are blocked by glibenclamide may contribute, at least in part, to the effects of KRN2391 and nicorandil on CBF and blood pressure (BP).

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Blood Pressure / drug effects
  • Coronary Circulation / drug effects*
  • Dogs
  • Dose-Response Relationship, Drug
  • Female
  • Glyburide / pharmacology*
  • Heart Rate / drug effects
  • Male
  • Niacinamide / analogs & derivatives*
  • Niacinamide / antagonists & inhibitors
  • Niacinamide / pharmacology
  • Nicorandil
  • Nifedipine / antagonists & inhibitors
  • Nifedipine / pharmacology*
  • Potassium Channels / drug effects
  • Pyridines / antagonists & inhibitors
  • Pyridines / pharmacology*
  • Vascular Resistance / drug effects


  • Antihypertensive Agents
  • Potassium Channels
  • Pyridines
  • N-cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate
  • Niacinamide
  • Nicorandil
  • Nifedipine
  • Glyburide